X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. NOVARTIS FDC LTD./
NOVARTIS
 
P/E (TTM) x 18.9 375.3 5.0% View Chart
P/BV x 3.8 33.0 11.4% View Chart
Dividend Yield % 1.3 1.4 90.6%  

Financials

 FDC LTD.   NOVARTIS
EQUITY SHARE DATA
    FDC LTD.
Mar-14
NOVARTIS
Mar-18
FDC LTD./
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs144758 18.9%   
Low Rs79579 13.6%   
Sales per share (Unadj.) Rs47.6228.4 20.8%  
Earnings per share (Unadj.) Rs7.631.7 24.0%  
Cash flow per share (Unadj.) Rs9.032.8 27.5%  
Dividends per share (Unadj.) Rs2.2510.00 22.5%  
Dividend yield (eoy) %2.01.5 135.2%  
Book value per share (Unadj.) Rs47.5297.1 16.0%  
Shares outstanding (eoy) m177.8324.69 720.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.32.9 79.9%   
Avg P/E ratio x14.621.1 69.4%  
P/CF ratio (eoy) x12.320.4 60.5%  
Price / Book Value ratio x2.32.2 104.0%  
Dividend payout %29.631.5 93.8%   
Avg Mkt Cap Rs m19,78416,505 119.9%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m1,2211,445 84.4%   
Avg. sales/employee Rs ThNM8,441.3-  
Avg. wages/employee Rs ThNM2,163.6-  
Avg. net profit/employee Rs ThNM1,173.1-  
INCOME DATA
Net Sales Rs m8,4595,639 150.0%  
Other income Rs m3941,718 22.9%   
Total revenues Rs m8,8527,357 120.3%   
Gross profit Rs m2,070-63 -3,312.3%  
Depreciation Rs m24925 984.6%   
Interest Rs m3155 56.1%   
Profit before tax Rs m2,1841,575 138.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606792 76.5%   
Profit after tax Rs m1,353784 172.7%  
Gross profit margin %24.5-1.1 -2,208.1%  
Effective tax rate %27.750.3 55.2%   
Net profit margin %16.013.9 115.1%  
BALANCE SHEET DATA
Current assets Rs m4,3559,522 45.7%   
Current liabilities Rs m1,7923,296 54.4%   
Net working cap to sales %30.3110.4 27.4%  
Current ratio x2.42.9 84.1%  
Inventory Days Days4437 121.4%  
Debtors Days Days2528 86.8%  
Net fixed assets Rs m3,02546 6,576.1%   
Share capital Rs m179123 144.7%   
"Free" reserves Rs m8,2437,213 114.3%   
Net worth Rs m8,4537,336 115.2%   
Long term debt Rs m110-   
Total assets Rs m10,55711,105 95.1%  
Interest coverage x71.429.5 242.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 157.8%   
Return on assets %13.17.6 173.6%  
Return on equity %16.010.7 149.9%  
Return on capital %23.522.2 105.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14661 1,891.3%   
Fx outflow Rs m3553,630 9.8%   
Net fx Rs m791-3,570 -22.2%   
CASH FLOW
From Operations Rs m1,4851,610 92.2%  
From Investments Rs m-620687 -90.2%  
From Financial Activity Rs m-753-2,677 28.1%  
Net Cashflow Rs m113-380 -29.7%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.7 2.0 235.0%  
FIIs % 7.5 1.6 468.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 21.5 88.4%  
Shareholders   23,730 41,647 57.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   IPCA LABS  GSK PHARMA  PANACEA BIOTECH  MERCK LTD  SANOFI INDIA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Dec 11, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS